HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis
Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis
Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells
Multicentric breast cancer: clonality and prognostic studies
Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma
Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma
SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer
High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer
Acquisition of metastatic tissue from patients with bone metastases from breast cancer
Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs
Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2
Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance
Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?
Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer
First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study
The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures
Oncological and cosmetic outcome in breast cancer patients undergoing “moving window” operation
Excised and irradiated volumes in relation to the tumor size in breast-conserving therapy
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation
The association between chronic disease burden and quality of life among breast cancer survivors in Missouri
Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer
Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population
The effect of system-level access factors on receipt of reconstruction among Latina and white women with DCIS
Well-done meat intake and meat-derived mutagen exposures in relation to breast cancer risk: the Nashville Breast Health Study
Second events following ductal carcinoma in situ of the breast: a register-based cohort study
A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families
Evidence for a link between TNFRSF11A and risk of breast cancer
Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study
Second primary breast, endometrial, and ovarian cancers in Black and White breast cancer survivors over a 35-year time span: effect of age
Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicing
MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism
The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in Europeans
Effect of the overexpression of BRCA2 unclassified missense variants on spontaneous homologous recombination in human cells
Data in a recent meta-analysis about TNF-alpha polymorphisms and breast cancer susceptibility need for clarification
Associations between polymorphisms of tumor necrosis factor-α gene and breast cancer risk
RAD51C germline mutations in Chinese women with familial breast cancer
Regarding the article “The p160 ER co-regulators predict outcome in ER negative breast cancer” by Spears, Oesterreich, Migliaccio et al. published in Breast Cancer Res Treat, March 2011
Lack of association between hOGG1 Ser326Cys polymorphism and breast cancer susceptibility in European population